olanzapine and 24-25-oxidolanosterol

olanzapine has been researched along with 24-25-oxidolanosterol* in 1 studies

Other Studies

1 other study(ies) available for olanzapine and 24-25-oxidolanosterol

ArticleYear
Improved biopharmaceutical performance of antipsychotic drug using lipid nanoparticles via intraperitoneal route.
    Pharmaceutical development and technology, 2022, Volume: 27, Issue:7

    This study aims to develop, characterize, and examine olanzapine-loaded solid lipid nanocarriers (OLAN-SLNs) for effective brain delivery. OLAN has poor water solubility and low penetration through blood-brain barrier (BBB). Herein, OLAN-SLNs were fabricated using high-pressure homogenization (HPH) method followed by their investigation for particle properties. Moreover,

    Topics: Animals; Antipsychotic Agents; Biological Products; Cyclooxygenase 2; Delayed-Action Preparations; Drug Carriers; Lanosterol; Lipopolysaccharides; Liposomes; Mice; Nanoparticles; NF-kappa B; Olanzapine; Particle Size; Suspensions

2022